Filipendula ulmaria (L.) Maxim (meadowsweet) is a popular medicinal species that can be found throughout most Europe and Asia. The plant is known for its rich antioxidants content, having compounds such as flavonoids and ascorbic acid. Therefore, the aim of 
Introduction
Plants have been used as traditional medicines throughout the centuries (Novais et al., 2004 ) and nowadays they still play an important role in human therapy, according to the World Health Organization (WHO, 2002) . Indeed, in some Asian and African countries 80% of the population use traditional medicine (including plant based medicines) as primary health care (Panda, 2012) .
Filipendula ulmaria (L.) Maxim, commonly known as meadowsweet, is an interesting example of useful plants reported by several ethnobotanical surveys and can be found not only in the Iberian Peninsula, but also in other regions of most of Europe and Western Asia, such as Poland and Russia (Barros et al., 2013) . Homemade remedies prepared from this species have been described since the late 16 th and 17 th centuries.
Sweet tea is made from the dried flower and has been used for supportive treatment of common cold, relief of minor articular pain (analgesic properties), or to facilitate renal
and digestive elimination functions. After an evaluation of the pharmacologic effects, in vitro and animal studies suggest that it has anti-inflammatory/immunomodulatory, antibacterial and anticarcinogenic activities (Rauha et al., 2000; Churin et al., 2008; Yildirim and Turker, 2009; Nesterova et al., 2009; Cwikla et al., 2010) To our knowledge, there are only two studies (not published in English), which have been carried out in order to investigate the tumour cell growth inhibitory activity of extracts from F. ulmaria. In one of those studies, carried out in Raji (Burkitt lymphoma cells), the authors state that ethanolic extracts of F. ulmaria were cytotoxic to those cells, at concentrations of 10 and 50 µg/ml (Peresun'ko et al., 1993) . The other study
indicates that the local administration of decoction flower extracts in mice with cervical dysplasia had beneficial effects in the frequency of squamous-cell carcinoma of the 4 cervix and vagina induced in mice by 7,12-dimethyl-benz(a)anthracene treatment (Spiridonov et al., 2005) .
Plant material gathered in Portugal has revealed rich antioxidants content, having compounds such as phenolic compounds, α-tocopherol and ascorbic acid. Regarding the phenolic compounds, phenolic acids (caffeic acid derivatives and gallic acid), flavonols (glycosides of quercetin and isorhamnetin) and ellagitannins (digalloylhexahydroxydiphenol-glucose and trigalloyl digalloyl-hexahydroxydiphenol-glucose) have been described (Barros et al., 2013) .
In the present work, the tumour cell growth inhibitory potential of F. ulmaria flower extracts was investigated in three different human tumour cell lines: NCl-H460 (nonsmall cell lung cancer), A375-C5 (melanoma) and MCF-7 (breast adenocarcinoma).
The most potent extract was further studied regarding its effect in cellular proliferation, cell cycle and programmed cell death.
Material and Methods

Samples and preparation of the extracts
The top The samples to be studied were lyophilized (Ly-8-FM-ULE, Snijders, Netherlands) and further submitted to four different extraction methodologies ( Table 1) .
For infusion preparation the lyophilized material (1 g) was added to 200 ml of boiling distilled water and left to stand at room temperature for 5 min, and then filtered under reduced pressure. Stock solutions of all extracts were prepared in DMSO at a concentration of 100 mg/ml and further stored at -20ºC.
Cell culture
The human tumour cell lines used in the study were: NCl-H460 (non-small cell lung cancer, a kind gift from NCl, USA), A375-C5 (melanoma, ATCC) and MCF-7 (breast adenocarcinoma, ATCC). Cells were maintained in RPMI-1640 medium with ultraglutamine (Lonza, Pittsburgh, PA, USA) supplemented with 5% FBS (Gibco, Alfragide, Portugal), at 37ºC in a humidified incubator with 5 % CO 2. All the experiments were performed with exponentially growing cells presenting more than 90% cell viability.
Cell growth inhibition assay
Cells were plated in 96-well plates at their previously determined optimal concentrations and incubated for 24 hours to adhere. In the case of NCI-H460 and 6 MCF-7 cells, the appropriate density was 5.0x10 4 /ml, and in the case of A375-C5 cells the appropriate density was 7.5x10 4 /ml. The sulforhodamine assay was adapted from the procedure used in the NCI's in vitro anticancer drug screening (Vichai and Kirtikara 2006; Neves et al.; . Briefly, cells were treated with five serial dilutions of each extract, ranging from 25 µg/ml to 400 µg/ml. 
Preparation of cells for other analysis
For the analysis of cellular proliferation, NCI-H460 cells were plated at 1.5x10 5 cells/well in 6-well plates and incubated for 24 h. Cells were then treated with extract 2 (obtained by decoction) at its GI 50 and 2 x GI 50 concentrations. Blank cells (treated with medium) or control cells (treated with DMSO, equivalent to the GI 50 and 2 x GI 50 of the extract B) were also included. Cells were then analysed for cellular proliferation, cell cycle profile, programmed cell death or protein expression. The percentage of viable cells in relation to Blank cells was also confirmed, by trypan blue exclusion, 48 h after the addition of the extracts to the cells.
Cell proliferation analysis
Cellular proliferation was analysed according to the protocol previously described (Palmeira et al., 2010 (Vasconcelos et al., 2000) .
Analysis of programmed cell death
Following 48 h of treatment, cell pellets were fixed with 4 % paraformaldehyde in PBS and further stored in PBS at 4ºC. TUNEL assay was carried out using the "in situ cell death detection kit -fluorescein" (Roche, Amadora, Portugal) according to manufacturer´s instructions. Briefly, cell cytospins were incubated in an ice cold "Permeabilization Solution" (0.1% Triton®X-100 in 0.1% sodium citrate, Promega, Madison, USA) for 2 minutes and then incubated with TUNEL reaction mix (1:20 enzyme dilution, Roche, Amadora, Portugal) for 1 hour at 37ºC. Slides were mounted with Vectashield mounting medium (with DAPI). Cells were analysed using a fluorescence microscope and semi-quantitative evaluation of cells undergoing programmed cell death was assessed by counting a minimum of 500 cells per slide (Lima et al. 2004; Queiroz et al., 2013) . 
Protein expression analysis
Following 48 (Sigma, St. Louis, MO, USA) were used for signal detection, as previously described (Lima et al., 2006) .
Statistical analysis
The results of the four tested extracts were analyzed using one-way analysis of variance (ANOVA) followed by Tukey's HSD. In the remaining cases, results were analyzed by applying a Student's t-test (paired test). All tests were carried out using SPSS v. 20.0
program (SPSS Inc.), with P ≤ 0.05.
Results and Discussion
Effect of the flower extracts on tumour cell growth inhibition
All the extracts studied inhibited cell growth in the cell lines studied. Results obtained for the GI 50 concentrations (which inhibit cell growth by 50%) indicate that the most potent extract for the NCI-H460 and for the A375-C5 cells was extract 2 (obtained by decoction). In the MCF-7 cell, extracts 2, 3 and 4 presented similar effect and were slightly more potent than extract 1 ( Table 2) .
These results are in agreement with the ones obtained by the Russian study in the Raji cell line, in which extracts of F. ulmaria presented cytotoxic effects (Peresun'ko et al., 1993) . Nonetheless, the mechanisms behind such an effect are still not known.
Therefore, extract 2 (obtained by decoction) was selected to be further tested in the NCI-H460 cell line. This cell line was selected for being a cell line representative of lung cancer, one of the most mortal types of cancer.
Effect of extract 2 on NCI-H460 cellular proliferation
The effect of this extract on the proliferation of NCI-H460 cells was assessed with the BrdU incorporation assay. Results clearly show that this extract reduces cellular proliferation. Nevertheless, the effect was most evident only with the 2xGI 50 concentration ( Table 3) .
The lower effect on cellular proliferation obtained with the GI 50 concentration could be justified by the fact that the SRB assay is based on the protein cellular content and not on cell number. Indeed, when the effect of the same concentrations of extract was studied regarding viable cell number, it was possible to conclude that the previously determined GI 50 concentration did not reduce the viable cell number but that the 2xGI 50 concentration reduced viable cell number to less that 50% (Figure 1 ). This is probably 11 because a reduction in cellular protein content does not necessarily represent a reduction in cellular viability, at least not at the same time. This situation was already reported in similar studies with other natural matrices previoulsy carried out by some of the authors .
Effect of extract 2 on NCI-H460 cell cycle profile
Considering the reduction in cellular proliferation observed, the effect of the extract on cell cycle profile was investigated. Results (Figure 2 ) indicate that treatment with the 2xGI 50 concentration of the extract caused a slight increase in the G1 phase of the cell cycle but this was not considered statistically significant. Nonetheless, considering the previously obtained results in cellular proliferation, an increase in the number of cells in the G1 phase of the cell cycle would make sense. In fact, cell cycle arrests cause decrease in cellular proliferation (Chen et al., 2010) .
Effect of extract 2 on NCI-H460 programmed cell death
The effect of this extract on programmed cell death was also analysed with the TUNEL assay. Results show that the extract did not cause any increase in programmed cell death, at the concentrations and time point analysed (Table 4) .
Effect of extract 2 on the expression levels of proteins involved in cellular proliferation and DNA damage, in NCI-H460 cells
Given the previous results, which indicated that the 2xGI 50 concentration of this extract reduced cellular proliferation and caused a slight alteration of the cell cycle profile at the studied time point, the effect of this concentrations and duration of treatment on the expression of cellular proteins involved in cell cycle was investigated. Results from Western Blots clearly showed that this treatment caused a statistically significant increase in the cellular levels of p21, and a non-statistically significant increase of p53 (Figure 3) .
The increase in p21 is particularly interesting, considering the indication that there was also a small increase in the number of cells in the G1 phase of the cell cycle, since p21
is a G1-checkpoint cyclin-dependent kinase inhibitor (Abukhdeir and Park, 2008) . It is well known that p21 expression is driven by p53 (Kuribayashi and El-Deiry, 2008 ) and therefore the increase in p53 found in our study could be the cause for the p21 increase.
Nonetheless, it is known that the p21 tumor suppressor not only plays a role in p53 signaling but interestingly also positively regulates p53 expression (Mirzayans et al., 2012) .
As p53 also controls apoptosis, alterations in the programmed cell death levels of treated cells would be expected but were not found in the present study. It is possible that if the study was extended to other concentrations and times of treatment, alterations in cell death would also be observed.
Since it is established that p53 expression could be increased as a result of DNA damage in wild-type p53 cells (Kuribayashi and El-Deiry, 2008 ), the present study was extended to look at the cellular protein levels of p-H2A.X following treatment with the extract. An increase in p-H2A.X levels was observed, even though this was not statistically significant, which is a possible indication of DNA damage (Tanaka et al., 2006) . These results will need to be further confirmed with other specific assays for DNA damage. In fact, such a result is surprising considering the fact that the flowers from this plant are known for their rich antioxidants content (Barros et al., 2011; Barros et al., 2013) . Nevertheless, those antioxidants might not be enough to avoid DNA damage, as least under the tested in vitro conditions.
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It would be interesting to isolate the compounds present in extract 2 of F. ulmaria and identify which one(s) are causing the inhibition of proliferation effect in the tumour cells.
Overall, flower extracts of F. ulmaria inhibit the growth of the studied human tumour cell lines. The most potent extract was the one obtained by decoction, whose effect on the NCI-H460 cells was due to a reduction in cellular proliferation, causing an increase in the cellular levels of p21. Data obtained highlight the potential interest of this plant as a source of bioactive compounds. 
